Corval provides a clear path from the clinic to the market, freeing innovative biopharma leaders to focus on getting treatments to the patients they serve.
Founder & CEO
Letter from Our Founder
It has often been said, life experience shapes who you are and where you focus your passions. Growing up in a large family with many siblings and different points of view, I learned early the value of navigating the inevitable day-to-day chaos to get to a place of resolution to keep moving forward!
I have applied this learning in my career, helping biopharma leaders understand that “commercialization is a mindset,” represented by an organization-wide effort to bring their innovative medicines to market.
After decades of work with hundreds of clients, I’ve witnessed the fragmented commercialization planning process and how it bogs down early- to mid-stage companies that have yet to build their internal capabilities.
As an entrepreneur, I knew there has to be a better way.
- There was a way to create a roadmap that is completely aligned with your company, product, and strategy?
- It was possible to create a budget and workforce plan from your own unique roadmap?
- This platform was designed with you in mind and was affordable for your company size and budget?
- You could utilize this platform on your own, or across your company, as a single source of truth?
At Corval, we are turning these “what ifs” into a full commercialization navigation tool that will guide your strategic planning and lead you from the clinic to the market, freeing you up to think bigger and drive innovation for the patients you are committed to serve.
We’re a team with big ideas committed to changing the way that innovative therapies get to patients. And we’re growing every day.
Susan is a proven leader and successful entrepreneur in the life science industry. In addition to founding and leading Corval, a novel SaaS platform company, she is the CEO and Founder of The NemetzGroup, a successful, strategic commercialization consultancy. The NemetzGroup has been instrumental in supporting the evolution of over 100 biopharma companies from startup to publicly traded and the development of numerous assets from targets to approved, life-saving treatments. With more than 35 years of corporate strategy, commercial, medical affairs, business development, and operational experience, C-suite leadership teams rely on her thought partnership and mentoring to achieve goals across all stages of drug development.
Prior to launching The NemetzGroup in 2003, Susan served as Vice President, Global Commercial Strategy, and then Vice President of International Commercial Operations at Millennium Pharmaceuticals. Previously, she progressed through multiple commercial leadership roles at DuPont Pharmaceuticals that culminated in her appointment as Executive Vice President of the cardiovascular and imaging franchise. Susan serves as an advisor of Life Science Cares, a collective effort of the life science industry to eliminate the impact of poverty on Boston neighborhoods. Susan received her BS in business management from the University of Minnesota.
Chief Strategy &
As Corval’s first employee and a member of the leadership team, Kristin has played a foundational role in creating the Corval platform. As Chief Strategy and Product Officer, Kristin leads strategic planning and product development efforts, overseeing the development and execution of all company workstreams in collaboration with the CEO. A reflection of her deep appreciation for entrepreneurship, this is Kristin’s fourth role with a startup company. She is also a former consultant with The NemetzGroup and has held senior management positions at several market research and consulting firms. Kristin has in-depth biopharma domain knowledge, having worked across multiple disciplines, including primary market research, market access, reimbursement, commercialization and launch consulting, healthcare policy, and medical device and drug development. She has a BA in Financial and Managerial Economics and Health Management and Policy from the University of New Hampshire and an MPH in Health Services from Boston University.
Meera joined Corval as Chief of Staff in 2020. She has over 20 years of B2B and B2C marketing experience and has spent the last 12 years helping build fintech startups in Boston. Most recently, Meera was Chief Marketing Officer at Gradifi, where she helped grow the company into a leading provider of financial wellness benefits before its acquisition by E*trade. Preceding that, she led marketing at SimpleTuition (acquired by LendingTree) and ValoreBooks (acquired by Follett). Before her work with startups, Meera honed her marketing skills at major consumer brands, including Sports Illustrated and Martha Stewart Living Omnimedia. Meera has a BA in Psychology from Brown University and an MBA from the Ross School of Business at the University of Michigan.
Casey joins Corval as a Business Analyst, where she is responsible for data analytics and insight mining to help drive product development efforts. Prior to joining Corval, Casey was a Corps Support Intern at City Year Boston, where she managed events and seminars for incoming members and external partners. Casey also served as a Public Affairs Intern at Planned Parenthood of Northern New England, where she assisted in a research study in collaboration with Duke University to determine the effectiveness of deep-canvassing initiatives. Casey is a recent graduate from Hamilton College, where she earned a BA in Government and Hispanic Studies. She is also a proud alum of NOLS, where she bravely led a team expedition through the Yukon, CA wilderness.
Kristin joins Corval as the Customer Engagement Director responsible for ensuring a personalized and meaningful customer experience from inquiry through product adoption. Kristin is an accomplished, results-oriented, and strategic commercial leader with diverse pharmaceutical expertise. She spent 17 years at Sanofi in various commercial positions, spanning sales, operations, lifecycle management, brand strategy and execution, and business development. She has US and global experience across numerous therapeutic areas and has managed portfolios from launch through authorized generics. In addition to her time at Sanofi, Kristin has served as a consultant for The NemetzGroup helping companies navigate the commercialization process. Her combined biopharma and consulting experience enable her to translate unique customer business needs to the Corval product team and facilitate an important customer-focused feedback loop. Kristin is a hands-on team leader and inspiring motivator with excellent analytical, problem-solving, and communication skills. She holds a BA in Economics from Boston College and an MBA in Finance from Villanova University.
Radhika Sabnis joined Corval in 2020 as a Business Project Manager, where she is responsible for overseeing all project activities related to operations and strategy. She has several years of project management experience in the biopharma and healthcare domain and has led complex workstreams spanning software implementation, manufacturing, operations, and quality and process improvement. In her recent position with Healthcentric Advisors, she worked with hospital systems and clinicians throughout Massachusetts to maintain healthcare quality compliance, streamline workflows, and maximize Medicare payments. She has held similar management and consulting roles at Partners HealthCare, Exeter Health Resources, and Lonza Biologics. In addition to her PMP certification, Radhika holds an MS in Genetic Engineering from Bangalore University and an MBA from the University of New Hampshire.
We couldn't do it without the help of our product and development partners.
We are a small and mighty team building a product at the exciting intersection of biopharma and technology.
We value our customers, our partners, and our people. We believe in a culture of learning, collaboration, empathy, and diversity. We believe that work and life should be in balance and that striving for excellence can co-exist with striving for happiness. If you are interested in helping us build this innovative company, learning a lot, and having fun while doing it, we’d love to hear from you.
Email us at firstname.lastname@example.org.
Follow us on LinkedIn.